Microrna Market Size, Share, Industry Trends and Forecast to 2033
This market report provides a comprehensive analysis of the Microrna market, focusing on key insights and quantitative data. The report covers the market forecast from 2023 to 2033, exploring trends, growth opportunities, segmentation, and regional analysis.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 9.2% |
| 2033 Market Size | $3.73 Billion |
| Top Companies | Thermo Fisher Scientific, Qiagen N.V., Illumina, Inc., F. Hoffmann-La Roche AG, Integrated RNA Technologies |
| Last Modified Date | 15 November 2024 |
Microrna Market Report (2023 - 2033)
Microrna Market Overview
What is the Market Size & CAGR of Microrna market in 2023?
Microrna Industry Analysis
Microrna Market Segmentation and Scope
Request a custom research report for industry.
Microrna Market Analysis Report by Region
Europe Microrna Market Report:
The Microrna market in Europe will grow from $0.47 billion in 2023 to $1.18 billion by 2033. Significant governmental funding for research, alongside collaborations between academia and industry, will enhance development and application of micrornas.Asia Pacific Microrna Market Report:
In the Asia Pacific region, the Microrna market is expected to grow from $0.29 billion in 2023 to $0.71 billion by 2033. The rising number of research initiatives and collaborations in genomics are facilitating market expansion, along with an increase in healthcare spending.North America Microrna Market Report:
North America, being a leader in biopharmaceutical research and development, holds a significant share of the Microrna market. It is expected to grow from $0.51 billion in 2023 to $1.28 billion by 2033, driven by technological advancements and high healthcare expenditure.South America Microrna Market Report:
The South American Microrna market is projected to increase from $0.10 billion in 2023 to $0.24 billion by 2033, fueled by growing investments in biotechnology and the demand for advanced medical diagnostics amidst rising healthcare accessibility.Middle East & Africa Microrna Market Report:
The Middle East and Africa region is anticipated to grow its Microrna market from $0.13 billion in 2023 to $0.32 billion by 2033. The expanding biotechnology sector and increasing research initiatives to focus on prevalent diseases will drive this growth.Request a custom research report for industry.
Microrna Market Analysis By Type
Global MicroRNA Market, By Type Market Analysis (2024 - 2033)
The MicroRNA market is predominantly driven by mature miRNAs, which accounted for a size of $1.28 billion in 2023, expected to rise to $3.17 billion by 2033. Precursor miRNAs represent a smaller share but are also growing, with a size of $0.22 billion in 2023 projected to reach $0.56 billion by 2033.
Microrna Market Analysis By Application
Global MicroRNA Market, By Application Market Analysis (2024 - 2033)
In terms of application, diagnostics dominate the market, with a value of $0.98 billion in 2023, projected to grow to $2.43 billion by 2033. Therapeutics follows closely, expected to increase from $0.43 billion to $1.06 billion in the same timeframe, facilitating the development of innovative treatments.
Microrna Market Analysis By End User
Global MicroRNA Market, By End-User Industry Market Analysis (2024 - 2033)
Biotechnology companies represent a significant share of the Microrna market, holding approximately 54.25% of the total market value in 2023. Pharmaceutical companies, academic research institutes, and contract research organizations also contribute, with respective shares of 21.1%, 12.89%, and 11.76%.
Microrna Market Analysis By Technology
Global MicroRNA Market, By Technology Market Analysis (2024 - 2033)
Quantitative Real-Time PCR (qPCR) is a leading technology, contributing 65.33% of the market in 2023, with expectations of increasing technological adoption in the coming years. Sequencing technologies and microarray technologies follow, facilitating advancements in microrna discovery and application.
Microrna Market Analysis By Region
Global MicroRNA Market, By Region Market Analysis (2024 - 2033)
The regional analysis reflects the broader trends in technology and healthcare investment. North America is the dominant region, with Europe also showing significant growth potential due to research collaborations. Asia Pacific is emerging, driven by increasing healthcare infrastructure and research funding.
Microrna Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Microrna Industry
Thermo Fisher Scientific:
A leading global provider of scientific instrumentation and reagents, Thermo Fisher is at the forefront of microrna research solutions, offering a comprehensive range of products for genomics research.Qiagen N.V.:
Qiagen is a prominent player in sample and assay technologies, offering specialized products and services that facilitate the development of microrna-based diagnostics and therapeutics.Illumina, Inc.:
Illumina, a leader in DNA sequencing and array-based solutions, provides innovative technologies that significantly contribute to microrna discovery and biomarker research.F. Hoffmann-La Roche AG:
Roche is a major pharmaceutical company that has integrated microrna technology into its research and development pipeline, focusing on innovative therapeutic solutions for chronic diseases.Integrated RNA Technologies:
A key provider of custom RNA oligonucleotides, Integrated RNA Technologies supports various applications in the microrna space, catering to both research and clinical demands.We're grateful to work with incredible clients.
